ARAY
- Accuray Incorporated
()
Overview
Company Summary
Accuray Incorporated (ARAY) is a medical technology company that focuses on the development, manufacturing, and sale of radiotherapy systems for the treatment of cancer and other related diseases. The company specializes in the design and production of image-guided radiosurgery and precision radiation therapy solutions.
Accuray's flagship product is the CyberKnife System, an advanced robotic radiosurgery system that delivers high doses of radiation precisely to tumors. The CyberKnife System uses real-time imaging and software to track the tumor's position, adjusting the radiation beams accordingly, thereby minimizing damage to surrounding healthy tissue.
The company also offers the TomoTherapy System, which combines intensity-modulated radiation therapy (IMRT) and computed tomography (CT) imaging capabilities into an integrated platform. This system allows for highly precise tumor targeting, enabling clinicians to deliver personalized treatment plans.
Accuray's technology is designed to improve treatment outcomes, reduce side effects, and increase patient comfort. Their radiotherapy solutions are used in various clinical settings, including hospitals, cancer centers, and clinics worldwide.
Additionally, Accuray provides comprehensive training, education, and support services to help healthcare professionals effectively utilize their systems. The company is dedicated to advancing radiation therapy and providing innovative solutions to enhance patient care in the field of oncology.